Solid Biosciences (SLDB) Operating Income Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 80.62% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 8.65% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 1.27% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1,386.07% |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | -43.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.08% |
| Dec 31, 2025 | -23.83% |
| Sep 30, 2025 | -36.60% |
| Jun 30, 2025 | -50.04% |
| Mar 31, 2025 | -49.10% |
| Dec 31, 2024 | -79.19% |
| Sep 30, 2024 | -52.21% |
| Jun 30, 2024 | -3.52% |
| Mar 31, 2024 | 16.13% |
| Dec 31, 2023 | 35.59% |
| Sep 30, 2023 | -9.38% |
| Jun 30, 2023 | -5.76% |
| Mar 31, 2023 | -26.24% |
| Dec 31, 2022 | -85.32% |
| Sep 30, 2022 | -17.20% |
| Jun 30, 2022 | -35.84% |
| Mar 31, 2022 | -50.25% |
| Dec 31, 2021 | 12.62% |
| Sep 30, 2021 | 15.05% |
| Jun 30, 2021 | 1.52% |
| Mar 31, 2021 | 37.13% |
| Dec 31, 2020 | 33.97% |
| Sep 30, 2020 | 28.57% |
| Jun 30, 2020 | 29.65% |
| Mar 31, 2020 | 11.36% |
| Dec 31, 2019 | -44.42% |
| Sep 30, 2019 | -55.18% |
| Jun 30, 2019 | -48.36% |
| Mar 31, 2019 | -89.71% |
| Dec 31, 2018 | -47.66% |
| Sep 30, 2018 | -39.82% |
| Jun 30, 2018 | -52.92% |
| Mar 31, 2018 | -13.18% |